Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Sales (2016 - 2025)

Historic Return on Sales for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 0.13%.

  • Bio-Techne's Return on Sales rose 100.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.02%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.02% for FY2025, which is 900.0% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Return on Sales is 0.13%, which was up 100.0% from 0.13% recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Return on Sales ranged from a high of 44.87% in Q3 2022 and a low of 0.22% during Q2 2025
  • Over the past 5 years, Bio-Techne's median Return on Sales value was 0.16% (recorded in 2023), while the average stood at 2.37%.
  • In the last 5 years, Bio-Techne's Return on Sales skyrocketed by 446000bps in 2022 and then crashed by -446800bps in 2023.
  • Quarter analysis of 5 years shows Bio-Techne's Return on Sales stood at 0.27% in 2021, then tumbled by -31bps to 0.18% in 2022, then tumbled by -45bps to 0.1% in 2023, then grew by 17bps to 0.12% in 2024, then increased by 9bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q4 2025, 0.13% for Q3 2025, and 0.22% during Q2 2025.